2016
EASD 2016
Altering the course of type 1 diabetes
Mohammad Alhadj Ali
Dr. Mohammad Alhadj Ali
Proinsulin peptide immunotherapy in new-onset type 1 diabetes is well-tolerated and associated with reduced daily insulin usage || Oral Presentation #108
.

To view this page ensure that Adobe Flash Player version 10.2.0 or greater is installed.

Get Adobe Flash player
There are no comments yet. Be the first one to post a comment.
Related To This Webcast